Forty mph winds pelted cold rain against the runners as they approached the Boston Marathon’s infamous Heartbreak Hill. It was just before this mark that runner Courtney Duckworth’s eyesight started to blur. She couldn’t tell if her senses were warped from the terrible weather conditions or if it was something more serious. Living with Type 1 diabetes, she is used to keeping track of her health while she runs.
from MobiHealthNews https://ift.tt/2HOzWUb
April 21, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Valencell's partnership with earphone manufacturer leads to $10.5M raiseBiometric sensor technology company Valencell announced this week that it has raised $10.5 million in Series E, bringing the company’s total funding to $35 million. The new backing primarily comes as the result of a strategic… Read More
In-Depth: Consumer genomics furthers healthcare foothold but privacy, resource concerns persistIn the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its foothold within the healt… Read More
Care, wellness robotics company Embodied collects $22MPasadena, California-based Embodied announced today it has raised $22 million in Series A funding to support its AI and robotics platforms for improved care and wellness. The investment is led by Calibrate Ventures and Jazz V… Read More
Benchling gets $14.5M to build collaboration tools for biotechs, pharmasBenchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional partici… Read More
FDA grants DreaMed's de novo request for device-friendly diabetes softwareThe FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. from MobiHealthNews https://ift.tt/2JY1LcV … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment